New Service will be available!! – Support Package for Foreign CEOs in Japan
■ Who is this for?
Foreign CEOs who wish to establish a pharmaceutical company (Kabushiki Kaisha) in Japan with a Japanese co-representative (COO).
Recommended: Prepare at least 51% of the initial capital to secure majority ownership and management control.
(Note: This is not a legal requirement under the Companies Act.)
Legally, at least one representative director must have a registered address in Japan.
■ Can foreigners establish a company in Japan?
Yes. A foreign national can establish a KK or GK without living in Japan.
Condition: appoint a Japanese COO or co-representative who resides in Japan.
With this structure, the foreign CEO can own and manage the company without obtaining a Business Manager Visa.
If desired, the CEO may later relocate to Japan by applying for a Business Manager Visa as an option.
■ Capital
Legally: from 1 JPY.
Practically recommended:
JPY 5 million+ to demonstrate financial credibility.
JPY 10 million+ if applying for a Marketing Authorization Holder (MAH) license.
■ Our Support
Pre-market evaluation & regulatory training (GMP, GxP, licenses).
Company setup: COO introduction, incorporation, bank account, office search, tax accountant.
Advanced: MAH license, CRO/CDMO partnerships, recruitment, fundraising.
Optional: Business Manager Visa support (only if the CEO wishes to live and manage directly in Japan).
■ Timeline
Company incorporation: 1–2 months.
MAH license (if needed): 6–12 months.
Business launch possible within 6–12 months.
■ Outcomes
Company legally incorporated in Japan.
Foreign CEO can manage from abroad without residency.
Visa available later as an option for relocation.
■ Fees
Monthly subscription model.
Standard support: 6–12 months.
■ Contact Us
We provide a customized support plan tailored to your business needs.
Call us!!
🎯 Recommended For
Pharmaceutical and biotech companies planning entry into the Japanese market
Companies preparing for GMP inspections or foreign manufacturer accreditation
Firms developing generics or biosimilars for Japan
Executives and regulatory affairs professionals seeking systematic knowledge of Japanese regulations
👉 Take your first step into the Japanese market with confidence.
📩 For inquiries and registration, please contact me via message.
💡 Proposals from seminar organizers are also welcome.
💼 We also offer tailor-made in-house training seminars for company staff.
Date |
x/x/2025(10:00~16:00 JST) |
---|---|
Speaker
|
Satoru SUZUKI (SSPO LLC, CEO) |
見出し
|
表示したいテキスト
|
Date |
Coming soon
|
---|---|
見出し
|
表示したいテキスト
|